MA53482B1 - Thérapie d'infections par le papillomavirus humain à haut risque - Google Patents
Thérapie d'infections par le papillomavirus humain à haut risqueInfo
- Publication number
- MA53482B1 MA53482B1 MA53482A MA53482A MA53482B1 MA 53482 B1 MA53482 B1 MA 53482B1 MA 53482 A MA53482 A MA 53482A MA 53482 A MA53482 A MA 53482A MA 53482 B1 MA53482 B1 MA 53482B1
- Authority
- MA
- Morocco
- Prior art keywords
- acid
- human papillomavirus
- therapy
- following
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne une composition pharmaceutique contenant un composé de sélénite et un acide pharmaceutiquement acceptable, choisi parmi les suivants : l'acide citrique, l'acide acétique, l'acide malique, l'acide carbonique, l'acide sulfurique, l'acide nitrique, l'acide chlorhydrique, les acides de fruits et leurs mélanges. Cette composition est destinée à être utilisée pour la prévention ou le traitement d'une infection d'un organe reproducteur interne chez un patient féminin atteint d'au moins un papillomavirus humain (hpv) parmi les suivants : hpv16, hpv18, hpv31, hpv33 et hpv58. La composition est administrée par voie vaginale.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18191289.0A EP3616693A1 (fr) | 2018-08-28 | 2018-08-28 | Thérapie d'infections par le papillomavirus humain à haut risque |
| PCT/EP2019/072926 WO2020043762A1 (fr) | 2018-08-28 | 2019-08-28 | Thérapie pour infections par papillomavirus humain à haut risque |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA53482A MA53482A (fr) | 2021-07-07 |
| MA53482B1 true MA53482B1 (fr) | 2023-11-30 |
Family
ID=63442535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA53482A MA53482B1 (fr) | 2018-08-28 | 2019-08-28 | Thérapie d'infections par le papillomavirus humain à haut risque |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US20210299163A1 (fr) |
| EP (2) | EP3616693A1 (fr) |
| JP (1) | JP7420791B2 (fr) |
| CN (1) | CN112584828A (fr) |
| AR (1) | AR116027A1 (fr) |
| AU (1) | AU2019332079B2 (fr) |
| BR (1) | BR112021003360A2 (fr) |
| CA (1) | CA3107691C (fr) |
| CL (1) | CL2021000197A1 (fr) |
| EA (1) | EA202190441A1 (fr) |
| ES (1) | ES2958808T3 (fr) |
| GE (1) | GEP20227432B (fr) |
| HR (1) | HRP20231470T1 (fr) |
| HU (1) | HUE064691T2 (fr) |
| IL (1) | IL281080B2 (fr) |
| MA (1) | MA53482B1 (fr) |
| MD (1) | MD3843715T2 (fr) |
| MX (1) | MX2021002310A (fr) |
| PL (1) | PL3843715T3 (fr) |
| RS (1) | RS64916B1 (fr) |
| SM (1) | SMT202300340T1 (fr) |
| TW (1) | TWI827652B (fr) |
| UA (1) | UA127632C2 (fr) |
| WO (1) | WO2020043762A1 (fr) |
| ZA (1) | ZA202100375B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3875083A1 (fr) * | 2020-03-03 | 2021-09-08 | Selo Medical GmbH | Composition destinée à être utilisée dans un traitement d'anomalies de cellules cervicales contenant un composé de sélénite et d'acide |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003532608A (ja) | 2000-05-10 | 2003-11-05 | オーコファーム フォーシュンクス−ウント エントウィックルングス−ゲゼルシャフト ミット ベシュレンクテル ハフトング | 二酸化ケイ素の表面積を低減する方法 |
| AT412758B (de) | 2000-06-05 | 2005-07-25 | Vis Vitalis Lizenz & Handels | Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen |
| AT412448B (de) * | 2001-02-13 | 2005-03-25 | Vis Vitalis Lizenz & Handels | Verwendung von selenhältigen präparaten |
| AT412703B (de) | 2001-12-04 | 2005-06-27 | Vis Vitalis Lizenz & Handels | Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung |
| AT511159A1 (de) | 2011-02-16 | 2012-09-15 | Selo Medical Gmbh | Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen |
-
2018
- 2018-08-28 EP EP18191289.0A patent/EP3616693A1/fr not_active Withdrawn
-
2019
- 2019-08-20 TW TW108129683A patent/TWI827652B/zh active
- 2019-08-28 HR HRP20231470TT patent/HRP20231470T1/hr unknown
- 2019-08-28 RS RS20231165A patent/RS64916B1/sr unknown
- 2019-08-28 IL IL281080A patent/IL281080B2/en unknown
- 2019-08-28 BR BR112021003360-2A patent/BR112021003360A2/pt unknown
- 2019-08-28 GE GEAP201915586A patent/GEP20227432B/en unknown
- 2019-08-28 AU AU2019332079A patent/AU2019332079B2/en active Active
- 2019-08-28 ES ES19765421T patent/ES2958808T3/es active Active
- 2019-08-28 PL PL19765421.3T patent/PL3843715T3/pl unknown
- 2019-08-28 JP JP2021510859A patent/JP7420791B2/ja active Active
- 2019-08-28 EP EP19765421.3A patent/EP3843715B1/fr active Active
- 2019-08-28 EA EA202190441A patent/EA202190441A1/ru unknown
- 2019-08-28 SM SM20230340T patent/SMT202300340T1/it unknown
- 2019-08-28 WO PCT/EP2019/072926 patent/WO2020043762A1/fr not_active Ceased
- 2019-08-28 CA CA3107691A patent/CA3107691C/fr active Active
- 2019-08-28 CN CN201980055480.2A patent/CN112584828A/zh active Pending
- 2019-08-28 US US17/264,210 patent/US20210299163A1/en not_active Abandoned
- 2019-08-28 MX MX2021002310A patent/MX2021002310A/es unknown
- 2019-08-28 MA MA53482A patent/MA53482B1/fr unknown
- 2019-08-28 AR ARP190102447A patent/AR116027A1/es unknown
- 2019-08-28 HU HUE19765421A patent/HUE064691T2/hu unknown
- 2019-08-28 UA UAA202101331A patent/UA127632C2/uk unknown
- 2019-08-28 MD MDE20210608T patent/MD3843715T2/ro unknown
-
2021
- 2021-01-19 ZA ZA2021/00375A patent/ZA202100375B/en unknown
- 2021-01-25 CL CL2021000197A patent/CL2021000197A1/es unknown
-
2025
- 2025-05-21 US US19/214,622 patent/US20250281524A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (fr) | ||
| WO1995003056A1 (fr) | Inhibiteur de proliferation du virus de l'hepatite c | |
| WO2018067217A3 (fr) | Compositions comprenant des peptides courts dérivés de pedf et leurs utilisations | |
| JP2019529541A5 (fr) | ||
| CN102274174B (zh) | 苯并咪唑类药物油混悬剂 | |
| MA53482B1 (fr) | Thérapie d'infections par le papillomavirus humain à haut risque | |
| Gevorgyan et al. | A nodular-ulcerative form of secondary syphilis in AIDS | |
| CN114053475A (zh) | 一种抗hpv医用妇科敷料 | |
| WO2017038872A1 (fr) | Composition ayant une activité antifongique | |
| US20170296530A1 (en) | Compositions and Methods for Treating and Inhibiting Viral Infections | |
| US20230285441A1 (en) | Treatment of coronavirus infections with auranofin | |
| JP2015524460A5 (fr) | ||
| MA58262B1 (fr) | Composition destinée à être utilisée dans un traitement d'anomalies de cellules cervicales contenant un composé de sélénite et d'acide | |
| JPWO2019224779A5 (fr) | ||
| US20070098687A1 (en) | Pharmaceutical composition containing interferon for the treatment of hpv infections | |
| EP3241555A1 (fr) | Utilisation d'analogues de l'ion pyrophosphate pour le traitement de l'infection par vph | |
| Narayana et al. | Pathology of Infection and Infectious Diseases of the Oro‐Facial Complex | |
| RU2025131205A (ru) | Производные имидазотриазина в качестве модуляторов il-17 | |
| WO2012097634A1 (fr) | Médicament pour traiter l'infection par papillomavirus, et son utilisation dans l'élaboration de produits pharmaceutiques destinés au traitement de l'infection par papillomavirus | |
| RU2480202C1 (ru) | Способ реабилитации после деструктивных методов терапии при заболеваниях шейки матки, ассоциированных с папилломавирусной инфекцией | |
| EP4046646A1 (fr) | Compositions pharmaceutiques pour le traitement des infections par le hpv | |
| WO2023040990A1 (fr) | Nouveau médicament combiné pour le traitement d'infections à coronavirus, composition pharmaceutique et utilisation associée | |
| Cantor et al. | Metrorrhagia in a human immunodeficiency virus positive woman caused by cervical histoplasmosis | |
| WO2012007658A4 (fr) | Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives | |
| Kachalina et al. | Efficiency of using epigen intim in combination with a radiowave surgery technique to treat preinvasive cervical neoplasias in reproductive-aged women |